Table 2.
Scales (N)/Quartiles | Prev. (%) | PR | 95%CI | p Value * |
---|---|---|---|---|
Global prevalence (10,018) | 4.8 | |||
Effort (9987) | ||||
Quartile 1 | 3.85 | |||
Quartile 2 | 4.72 | 1.27 | 0.94–1.59 | |
Quartile 3 | 5.01 | 1.30 | 1.02–1.64 | <0.001 |
Quartile 4 | 6.29 | 1.63 | 1.28–2.08 | |
Reward (9619) | ||||
Quartile 1 | 8.53 | 3.75 | 2.79–5.04 | |
Quartile 2 | 3.92 | 1.72 | 1.22–2.43 | |
Quartile 3 | 3.56 | 1.55 | 1.09–2.19 | <0.001 |
Quartile 4 | 2.27 | - | - | |
Over-commitment (9992) | ||||
Quartile 1 | 2.85 | - | - | |
Quartile 2 | 3.14 | 1.10 | 0.81–1.48 | |
Quartile 3 | 5.26 | 1.84 | 1.38–2.46 | <0.001 |
Quartile 4 | 8.61 | 3.01 | 2.34–3.87 | |
E-R ratio (9534) | ||||
Quartile 1 | 3.62 | - | - | |
Quartile 2 | 3.45 | 0.95 | 0.70–1.28 | |
Quartile 3 | 3.96 | 1.09 | 0.82–1.45 | <0.001 |
Quartile 4 | 8.38 | 2.31 | 1.81–2.95 |
* Wald Test was estimated to analysis of dose-response effect (prevalence of the depressive episodes according to ERI scales). Prev. = prevalence rate; PR = prevalence ratio; CI: Confidence Interval.